Calendario de promoción Sihuan Pharmaceutical Holdings Group Ltd.
Acerca de la empresa Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd., инвестиционная холдинговая компания, занимается исследованиями и разработками, производством, маркетингом и продажей фармацевтических и медицинских эстетических продуктов в Китайской Народной Республике. Предлагает препараты в онкологии, метаболизме, сахарном диабете, сердечно-сосудистых и цереброваскулярных заболеваниях, современной китайской медицине, а также в терапевтических областях промышленной конопли. más detalles| IPO date | 2007-03-23 |
|---|---|
| ISIN | BMG8162K1137 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Див.доход ао | 3.23 |
| Дивиденд ао | 0.021 |
| Сайт | https://www.sihuanpharm.com |
| Цена ао | 0.66 |
| Cambio de precio por día: | +3.13% (0.64) |
|---|---|
| Cambio de precio por semana.: | +11.86% (0.59) |
| Cambio de precio por mes: | +8.2% (0.61) |
| Cambio de precio en 3 meses.: | 0% (0.66) |
| Cambio de precio en seis meses: | +22.22% (0.54) |
| Cambio de precio por año: | +13.79% (0.58) |
| Cambio de precio en 3 años.: | -49.62% (1.31) |
| Cambio de precio en 5 años.: | -26.67% (0.9) |
| Cambio de precio desde principios de año.: | +1.54% (0.65) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 58197595 | 0.62 |
| Vanguard International Stock Index-Total Intl Stock Indx | 51842035 | 0.56 |
| iShares Core MSCI Emerging Markets ETF | 49326000 | 0.53 |
| DFA Emerging Markets Core Equity Portfolio | 30445000 | 0.33 |
| DFA Emerging Markets Small Cap Series | 14528000 | 0.16 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 12876000 | 0.14 |
| iShares Core MSCI Total International Stock ETF | 7391000 | 0.08 |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 5141000 | 0.06 |
| Avantis Emerging Markets Equity ETF | 5122000 | 0.05 |
| Avantis Emerging Markets Equity Fund | 5122000 | 0.05 |
| ETF | Compartir, % | Rentabilidad del año, % | Dividendos, % |
|---|---|---|---|
| SPDR S&P Emerging Markets Small Cap ETF | 0.03544 | 5.46 | 3.03583 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.01 | 9.39 | 3.09932 |
| Dimensional Emerging Markets Value ETF | 0.00952 | 17.07 | 4.19508 |
SPDR S&P China ETF
|
0.00848 | 17.02 | 3.40103 |
| Avantis Responsible Emerging Markets Equity ETF | 0.00636 | 17.6 | 3.1719 |
| Avantis Emerging Markets Equity ETF | 0.00557 | 8.77 | 3.60513 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.00329 | 15.96 | 3.34087 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00257 | 13.06 | 3.62488 |
| Avantis Emerging Markets Value ETF | 0.00176 | 14.12 | 4.22231 |
| SPDR Portfolio Emerging Markets ETF | 0.00105 | 11.59 | 3.1879 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.01 | 12.4 | 3.45 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Dr. Fengsheng Che | Co-Founder & Executive Chairman | 7.59M | 1962 (63 año) |
| Dr. Weicheng Guo | Deputy Chairman & CEO | 3.41M | 1964 (61 año) |
| Ms. Guili Miao | Deputy CEO, Chief Investment Officer, CFO & Executive Director | 3.3M | 1974 (51 año) |
| Dr. Jionglong Zhang | Executive Director | 804.05k | 1962 (63 año) |
| Ms. Yanling Chen | Joint Company Secretary & Executive Director | 1.79M | 1978 (47 años) |
| Mr. Kin Wai Li | Joint Company Secretary | N/A | 1989 (36 años) |
| Mr. Xianhui Meng | Deputy General Manager | 4.62M | 1964 (61 año) |
DIRECCIÓN: Hong Kong, Wan Chai, Office Tower Convention Plaza - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.sihuanpharm.com
Sitio web: https://www.sihuanpharm.com
